SGE Biotechnology Co., Ltd.

Our Technology

Enabling New Drug Research and Development with Technological Innovation

Light Guide Single B Antibody Screening Platform

Using the photoconductive antibody screening platform, antibody screening and sequence sequencing can be completed 7 days after animal immunization. On the screening chip, multiple types of detection such as protein binding, cell binding, and antibody blocking activity can be realized at the same time, greatly speeding up the process of antibody drug development and the probability of drug antibody discovery.

High-throughput Screening Platform For Murine Monoclonal Antibodies

Sieger biology has established a mouse monoclonal antibody screening platform based on hybridoma single cell sorting, which can complete the spleen fusion of 3-5 mice at a single time, and obtain 100-500 positive monoclonal antibodies from a single screening.

Nanobody Screening Technology Platform

Through alpaca immunization and phage screening, nanobodies against target molecules can be specifically screened; a rapid expression platform for nanobodies can be established, and the supernatant of 50 to 100 strains of 293 cells secreting VHH can be prepared at a single time, which can be quickly used for subsequent identification.

Efficient Preparation Platform Of Recombinant Protein Antigen

SGE biological established the use of computer-aided analysis design and self-optimization of eukaryotic serum-free protein expression system, can prepare high-quality recombinant protein antigen, for subsequent animal immunization.

Products

Promoting the Development of Big Health Industry with Product Innovation

Recombinant Human MST1

Recombinant Human Heregulinβ-1

Recombinant Human Wnt5a

Mouse Immune Adjuvant

Recombinant Human Noggin

Recombinant Human R-Spondin-1

Recombinant Human Wnt-3a

Wnt-surrogate

Learn more

News

Real-time attention to industry dynamics, we will provide you with accurate and reliable information

Company News

Always adhere to the quality of development, quality of survival principle.

Industry dynamics

Sincerely welcome the national seed industry colleagues and friends to visit the guidance

2023-07-13

Technology | Common slicing techniques

It is well known that many tools and materials including tissue or cell specimens to be studied are required in medical research, especially in the hot research of cancer. Specimens can be used to examine the shape and structure of cells (morphology), disease status, intra-and inter-cellular communication, and, therefore, how they were obtained from biopsies. Since most biological materials are both fragile and perishable, care must be taken to ensure that they are prepared and preserved correctly.

→

2023-07-13

Technology Sharing Comprehensive Guide to Antibody Preservation

Be sure to review the specific data on your antibodies for saving recommendations. We are not responsible for improperly stored antibodies. If stored and handled properly, the activity of most antibodies can be retained for months or even years.

→

2023-07-13

Good news! SGE BIOTECH was awarded the "National High-tech Enterprise" recognition!

A high-tech enterprise is an enterprise that continuously conducts research and development and transforms technological achievements in the high-tech fields supported by the state, forms the core independent intellectual property rights of the enterprise, and carries out production and operation activities on this basis. This award marks the recognition and affirmation of SGE BIOTECH's technological innovation and R&D capabilities, and it has officially entered the ranks of high-tech enterprises since then.

→

About SGE BIOTECH

SGE BIOTECH Co., Ltd. is located in the beautiful environment of Suzhou Industrial Park Bio-Nano Technology City. The company is established and operated by members with rich experience in technology research and development and corporate management. SGE BIOTECH is a company aiming at the bottleneck of early technology research and development and the pain point of market demand in the biomedical industry, and is committed to technological innovation and product iterative development, so as to provide high-quality and competitive products and services for industry customers. At present, we have established a high-throughput mouse monoclonal antibody screening platform and a nano-antibody screening technology platform, which has achieved a quantitative and qualitative leap in screening flux, and can obtain a large number of high-quality nano-antibody molecules and mouse monoclonal antibody molecules for customers in a short time. Welcome colleagues in the industry to negotiate and cooperate.

Learn more

Business License